Navigation Links
Children's national co-leads nationwide study of landmark sickle cell treatment
Date:8/18/2008

been routinely utilized to treat treatment-refractory leukemia and lymphoma for almost two decades," said Dr. Kamani, co-principal investigator of the study. "Preliminary results from the few unrelated donor transplants that have been performed for other non-malignant conditions show great promise for those who suffer a severely diminished quality of life due to sickle cell disease. Participants in this large-scale study will help us understand how to better treat, and possibly even cure, sickle cell disease for more people."

Starting in late August, the clinical trial will enroll 45 patients ages 3 to 16 with severe symptoms of sickle cell disease, including stroke, recurring acute chest syndrome, or frequent pain crises. For all marrow and cord blood transplants, patients must undergo intense chemotherapy to prevent their immune systems from rejecting donor cells. This study will use a reduced-intensity chemotherapy to minimize side effects and increase the likelihood that the donor cells will be accepted by the body. After the transplant, participants will be followed for two years to gauge the effectiveness of the transplant at minimizing the ravages of sickle cell disease.


'/>"/>

Contact: Emily Dammeyer
edammeye@cnmc.org
202-476-4500
Children's National Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Story tips from the US Department of Energys Oak Ridge National Laboratory, August 2008
2. [video] Michael DePasquale, CEO of BIO-key International, Inc., Discusses Q2 2008 Revenue Growth on WallSt.nets 3-Minute Press Show
3. NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008
4. New study spotlights National Institutes of Health grant outcomes for clinical research
5. International conference to release new findings on smell and taste
6. National Institutes of Health award Williams professor $217,710 research grant
7. Story tips from the Department of Energys Oak Ridge National Laboratory, July 2008
8. International team identifies 21 new genetic risk factors for Crohns disease
9. 2008 ASABE Annual International Meeting
10. PharMEDium Announces National Rollout of Electronic 222 Ordering Initiative
11. Oak Ridge pegged for national ecological network
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Genome BC collaborates with Chile and Norway to sequence salmon genome 2A virtual physician's conference 2Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Allscripts and Medfusion Partner to Provide Patient Portal to Physician Practices Nationwide 52292 1Allscripts and Medfusion Partner to Provide Patient Portal to Physician Practices Nationwide 52292 2Allscripts and Medfusion Partner to Provide Patient Portal to Physician Practices Nationwide 52292 3Allscripts and Medfusion Partner to Provide Patient Portal to Physician Practices Nationwide 52292 4EPA Refuge Determination Positive for the Environment 13125 1EPA Refuge Determination Positive for the Environment 13125 2The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 52289 1The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 52289 2The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 52289 3The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 52289 4The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 52289 5